QT
FLNA

Quantbot Technologies’s Filana Therapeutics FLNA Stock Holding History

Quantbot Technologies’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,091
Closed -$268K – 1933
2023
Q3 		$268K Buy
+16,091
New +$319K 0.02% 818
2022
Q4 		– Sell
-100
Closed -$4K – 2052
2022
Q3 		$4K Buy
+100
New +$2.7K ﹤0.01% 1490
2021
Q1 		– Sell
-5,007
Closed -$34K – 1722
2020
Q4 		$34K Buy
+5,007
New +$44.7K ﹤0.01% 933

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Quantbot Technologies's FLNA Position: Q4 2023 in Review

Quantbot Technologies sold out of Filana Therapeutics (FLNA) in Q4 2023, closing a stake of 16,091 shares — an estimated $268K sold.

Quantbot Technologies first reported a position in FLNA in Q4 2020 and held it in 3 quarters. The position peaked at $268K in Q3 2023. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2023.

  • Quantbot Technologies reported no remaining Filana Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 16,091 Filana Therapeutics shares in Q4 2023, an estimated $268K.
  • Quantbot Technologies first reported a position in Filana Therapeutics in Q4 2020 and held it in 3 quarters.
  • Quantbot Technologies's Filana Therapeutics position peaked at $268K in Q3 2023.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.